Welcome subscribers,
This week, we examine the medtech sector and its real estate - how Europe's €160 billion (£134 billion) sector navigates lease-or-buy decisions. There is also a roundup of major deals spanning leases, acquisitions and developments.
✅ Germany: sterile facility in Homburg
✅ UK: Revvity expands to Alderley
🔒 Ireland: Astoriom expands storage capabilities
🔒 Serbia: CTP builds SCHOTT facility
🔒 UK: BioNTech, British Land, Bruntwood bring building boom
(🔒 for paying members only)
Read below for full details.
— Stephen Ryan (connect with me on LinkedIn)
Medtech companies and their real estate
European medtech companies navigate complex real estate decisions across innovation clusters, balancing flexibility needs with regulatory requirements.
Transactions
GERMANY HOMBURG
Famar Group, a Greece-based European pharmaceutical CDMO, acquired a sterile production site in Homburg from MiP Pharma. The acquisition strengthens Famar's footprint in high-value dosage forms and expands capabilities in aseptic and lyophilised fill & finish. The Homburg facility recently underwent significant investment and modernisation. Once the transaction closes, Famar will operate seven facilities across Europe.
UK CHESHIRE
Global life sciences and diagnostics company Revvity selected Bruntwood SciTech's Alderley Park as the location for its newest UK base as part of national expansion plans. Revvity will occupy almost 6,000 sq ft of custom-designed, specialist lab space at Alderley Park. The move supports Revvity's research collaboration with Genomics England and NHS England.
UK LONDON
Sovereign wealth fund GIC and Reef+Partners are working on plans for a £1 billion (€1.2 billion) life sciences and residential scheme at Royal College Place in Camden. The site, between Royal College Street and St Pancras Way in King's Cross, was acquired earlier this year from Royal Mail and Parcelforce for around £100 million (€119 million). Early designs feature two residential buildings alongside five commercial buildings around a public square. The redevelopment will transform the current Royal Mail Parcelforce facility into a mixed-use scheme focused on life sciences space and residential blocks.
👇 As a complimentary member, you get access to three deals for free.
Upgrade now to access the full list (11 more deals this week), including:
🔒 Ireland: Astoriom expands storage capabilities
🔒 Serbia: CTP builds SCHOTT facility
🔒 UK: BioNTech, British Land, Bruntwood bring building boom
